Sort by
Refine Your Search
-
ROLE SUMMARY At Pfizer we deliver breakthroughs that change patients' lives. In La Jolla, we are dedicated to the development of oncology agents that disrupt cancer biology or redirect the immune
-
with a background in hormone-driven cancers to join a dynamic and fast-paced discovery biology team. The successful candidate will join the Oncogene & Cancer Vulnerabilities group embedded within
-
of the Oncogenic Transcriptional Networks Group within the Cancer Cell Biology (CCB) Department. The candidate should have expertise in cell line engineering technologies, molecular and protein biology methods, and
-
, high-content/high-throughput screening, molecular biology, and complex cellular models, to support and accelerate the deconvolution of novel therapeutic mechanisms across a diverse discovery portfolio
-
technology development Hands on experience in mRNA synthesis, purification, characterization, and translational profiling Strong understanding of RNA biology and modeling for RNA folding and RNA-protein
-
projects with a focus on antibody-drug conjugates (ADC) that target oncogenic pathways and processes. You will work as a member of the ADC Biology team, performing a range of in vitro pharmacology and
-
/ project team independently and proactively. Perform laboratory experiments to help establish robust disease biology, biochemical and cell-based compound screening assays and carry out in vivo evaluation
-
Laboratory Practices (GCLP) requirements. Develop assays or animal models required to support various vaccine projects. Develop tool assets for advancing systems biology group projects including cell models
-
timely documentation of experiments in a laboratory notebook Qualifications Must-Have BS degree in biology, chemistry, biochemistry, chemical engineering, or related field with 2-5 years relevant
-
, Chemical Biology, or related discipline OR M.S. degree in Chemistry, Biochemistry, Chemical Biology, or related discipline with minimum 7 years experience, with 3 of those years in the biopharmaceutical